SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-15-002097
Filing Date
2015-03-26
Accepted
2015-03-26 09:58:33
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2014_immucellcorp.htm 10-K 1011309
2 CONSENT OF BAKER NEWMAN & NOYES, LLC f10k2014ex23_immucellcorp.htm EX-23 3473
3 CERTIFICATION f10k2014ex31_immucellcorp.htm EX-31 8018
4 CERTIFICATION f10k2014ex32_immucellcorp.htm EX-32 4966
11 GRAPHIC image_001.gif GRAPHIC 14302
12 GRAPHIC image1.jpg GRAPHIC 35195
13 GRAPHIC image2.jpg GRAPHIC 28581
  Complete submission text file 0001213900-15-002097.txt   6589747

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE iccc-20141231.xml EX-101.INS 852197
6 XBRL SCHEMA FILE iccc-20141231.xsd EX-101.SCH 42475
7 XBRL CALCULATION FILE iccc-20141231_cal.xml EX-101.CAL 73560
8 XBRL DEFINITION FILE iccc-20141231_def.xml EX-101.DEF 105577
9 XBRL LABEL FILE iccc-20141231_lab.xml EX-101.LAB 409579
10 XBRL PRESENTATION FILE iccc-20141231_pre.xml EX-101.PRE 284517
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 15726488
SIC: 2835 In Vitro & In Vivo Diagnostic Substances